CD47 and neoplasm: Our results verified peri-tumoral infiltration level of CD68+ macrophages compared to paired tumor samples of no BTS group and HL group, indicating macrophage-based therapeutics like CD47 blockade that promotes macrophage phagocytosis 40 being possibly feasible.